In 2007, researchers at the University of California, Los Angeles, published a study finding that the incidence of A.D.H.D. among teenagers in Finland, along with difficulties in cognitive functioning and related emotional disorders like depression, were virtually identical to rates among teenagers in the United States. The real difference? Most adolescents with A.D.H.D. in the United States were taking medication; most in Finland were not.
2007年,加州大学洛杉矶分校(University of California, Los Angeles, UCLA)的研究人员发表了一项研究,该研究发现,芬兰青少年中ADHD以及认知功能障碍和相关情绪障碍如抑郁症等的发病率与美国青少年中的几乎完全相同。真正的区别是:在美国,大多数青少年ADHD患者都服用药物;在芬兰却并非如此。
"It raises questions about using medication as a first line of treatment," said Susan Smalley, a behavior geneticist at U.C.L.A. and the lead author.
“这引起了人们对使用药物作为第一线治疗的质疑,”该研究的主要作者,UCLA的行为遗传学家苏珊·斯莫利(Susan Smalley)表示。
In a large study published last year in The Journal of the American Academy of Child & Adolescent Psychiatry, researchers reported that while most young people with A.D.H.D. benefit from medications in the first year, these effects generally wane by the third year, if not sooner.
【正念冥想有助于治疗注意力缺陷】相关文章:
★ 莫奈名画《干草堆》拍出1.1亿美元 创印象派画作价格新高
最新
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15